My lab is interested in the interface between cell and cancer biology. My group has had a long-term interest in the molecular machinery underlying mitosis and cytokinesis. This research has revealed that in addition to common themes, there is also significant variation between cell types in how cell division is accomplished. A current focus in the lab is to determine whether these differences can be leveraged to induce death due to aberrant mitosis in a cell type specific fashion as a chemotherapeutic strategy.